In Vitro Diagnostics (IVD) Market
Opportunities in Point-of-care (POC) Diagnostics for Cardiology and Oncology, along with Wearables, Stand out in the Market
Region : North AmericaAcross the world, women typically live longer than men. The reason behind the difference between male and female life expectancy is unclear but could be explained through biological, environmental, and behavioral factors. Because women typically outlive men, they are more likely to suffer from ill health and other age-related diseases. Women’s he...USD 1,500.00Read More
New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology
Region : North AmericaShortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...
Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection
Region : North AmericaPersonalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consoli...
Vital Signs - Advances in Cancer Treatment, Clampdown on Specialty Pharmacies and Strategy Revamp for Sequencing Provider, An Analysis
Liquid Biopsy Test for Prostate Cancer and Non-small Cell Lung Cancer Treatment Show Promise
Region : GlobalThis issue of Vital Signs discusses MDxHealth's launch of the SelectMDx Liquid Biopsy Test in Europe, the FDA's approval of a new treatment for non-small cell lung cancer with EGFR mutations, the clamp down on specialty pharmacies by US drug benefit managers, and BGI's strategy redirection for Complete Genomics.USD 450.00Read More
Public Hospital Service Outsourcing to Drive the Growth of Independent Reference Labs
Region : EuropeLaboratory consolidations and outsourcing of services are providing more opportunities to the clinical labs. How the market is going to shape up and how the laboratory services structure is transforming in Western Europe is analyzed in this research service. The study provides market overview, market engineering measurements and revenue forecasts, ...USD 6,000.00Read More
Trends, Challenges, and Best Practices for Stakeholders
Region : Asia PacificAsia-Pacific (APAC) point-of-care testing (POCT) market was worth $2.80 billion in 2014. In hospitals, POC is used more in emergency rooms (ERs), operation theatres (OTs), recovery rooms (RRs), cath labs, and intensive care units (ICU). The rental model in which the cost of the device is borne by the manufacturer while the profit is shared by the h...
Decentralization will Significantly Increase Retail Setting Test Volume by 2017
Region : North AmericaThis research service evaluates the US clinical laboratories market. The analysis provides extensive understanding of test distribution in independent laboratories (reference and specialized), physician office laboratories, hospital-based labs, and others including retail clinics and mobile diagnostic centers. The study covers the potential impact ...
Critical Sample Preparation Step Benefits from Downstream Applications
Region : North AmericaThe total market, as defined by this study, includes nucleic acid purification and isolation reagents (including kits and homebrew reagents) and nucleic acid purification and isolation instruments in the United States. The study period runs from 2011 to 2021, with 2014 as the base year and 2015–2021 as the forecast period. This research service o...
Cartridge-based Next Generation Flow Cytometry Instruments Broaden Applications in Clinical Market
Region : North AmericaGlobally, flow cytometry remains a popular tool for research applications including immuno-phenotyping, cell proliferation, cancer, and stem cells. But the market is witnessing active partnerships in clinical applications primarily because of demand from underdeveloped nations to quantitate CD4 cell markers in HIV patients. In this research, the to...USD 6,950.00Read More
Constricting Reimbursement Policies Restrain Market Growth
Region : North AmericaThe diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...USD 6,950.00Read More